STENT THROMBOSIS AFTER EVEROLIMUS-ELUTING VERSUS PACLITAXEL-ELUTING CORONARY STENTS: INSIGHTS FROM THE SPIRIT II, SPIRIT III, SPIRIT IV AND COMPARE POOLED DATABASE

Ajay J. Kirtane, Poornima Sood, Robert J. Applegate, Manejeh Yaqub, Yoshinobu Onuma, John C. Wang, Xiaolu Su, Karine Miquel‐Hébert, Alexandra J. Lansky, Dean J. Kereiakes, Charles A. Simonton, Krishnankutty Sudhir, Patrick W. Serruys, Gregg W. Stone

Circulation

Article2010

Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: pooled analysis of 3-year clinical outcomes from the Spirit II and III Trials

Alexandra J. Lansky, James Hermiller, Robert J. Applegate, Adriano Caixeta, Paul Gordon, Peter Ruygrok, Julie Doostzadeh, Karine Miquel‐Hébert, Susan Veldhof, Poornima Sood, Xiaolu Su, Krishnankutty Sudhir, Patrick W. Serruys, Gregg W. Stone

Cardiovascular revascularization medicine

Article2011

PERCUTANEOUS REVASCULARIZATION IN MULTIVESSEL CORONARY DISEASE IS IMPROVED WITH EVEROLIMUS-ELUTING STENT DEPLOYMENT: POOLED ANALYSIS FROM THE SPIRIT II IIIIV AND COMPARE TRIALS

Dean J. Kereiakes, Pieter C. Smits, Elvin Kedhi, Helen Parise, Martin Fahy, Patrick W. Serruys, Gregg W. Stone

Journal of the American College of Cardiology

STENT THROMBOSIS AFTER EVEROLIMUS-ELUTING VERSUS PACLITAXEL-ELUTING CORONARY STENTS: INSIGHTS FROM THE SPIRIT II, SPIRIT III, SPIRIT IV AND COMPARE POOLED DATABASE

Abstract

Discussion(0)

Related publications

EVEROLIMUS-ELUTING VS. PACLITAXEL-ELUTING STENTS. TWO-YEAR RESULTS FROM A PATIENT-LEVEL POOLED ANALYSIS FROM THE SPIRIT II, III, IV AND COMPARE RANDOMIZED TRIALS

COMPARISON OF THE EVEROLIMUS-ELUTING AND PACLITAXEL-ELUTING STENTS IN PATIENTS WITH ACUTE AND STABLE CORONARY SYNDROMES. RESULTS FROM THE SPIRIT II, III, IV AND COMPARE TRIALS

Abstract 17174: Predictors of Stent Thrombosis after Everolimus-Eluting and Paclitaxel-Eluting Stents: The Pooled SPIRIT Randomized Trial Experience at Two Years of Follow-Up

Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: pooled analysis of 3-year clinical outcomes from the Spirit II and III Trials

PERCUTANEOUS REVASCULARIZATION IN MULTIVESSEL CORONARY DISEASE IS IMPROVED WITH EVEROLIMUS-ELUTING STENT DEPLOYMENT: POOLED ANALYSIS FROM THE SPIRIT II IIIIV AND COMPARE TRIALS